FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362597265> ?p ?o ?g. }

• W4362597265 endingPage "2050" @default.
• W4362597265 startingPage "2050" @default.
• W4362597265 abstract "Abstract Background: Breast cancer is the second most common cancer in women. In 2022, it accounted for 15% of total new cancer cases and is the number four cause of death among all cancer types. To benefit from precision medicine, distinguishing molecular subtypes for prognosis and treatment in a clinical setting is essential. While intrinsic subtype classification from NGS results of patients is well established, the approach has not been comprehensively described for patient-derived xenograft (PDX) models, which have been shown to be powerful in translational research. The National Cancer Institute's Patient-Derived Models Repository (NCI PDMR; https://pdmr.cancer.gov) provides rich information in developing the method. Materials and Methods: Normalized gene expression data of breast cancer PDX and patient specimens (originators) were extracted using tximport and DESeq2 based on RNA-seq analysis. The immunohistochemistry (IHC) was used to determine the status of ER, PR and HER2 receptor expression in these tumor specimens. The PAM50 classification was performed by the R package Genefu. For further analysis, the PAM50 centroids for all 5 subtypes were also obtained from Genefu. Results: Using the RNA-seq data from 43 PDX models (180 PDX samples, 4~6 samples/model), we were able to predict subtypes at the model level based on the PAM50 method: There are 1 Luminal A subtypes, 5 Luminal B; 6 Her2; 30 Basal and 1 Normal, which encompasses the whole spectrum of PAM50. Thirty originators were also included and there are 8 Luminal A, 9 Luminal B, 2 Her2 and 11 Basal. With the matched 11 originators and the PDX models, 91% of their predicted subtypes are identical; 0.80 Cohen’s kappa was obtained, indicating high inter-rater agreement. We also described subsequent analysis with IHC data-based subtypes. For the 10 originators having IHC-based subtypes, 90% agreement was observed; for 24 PDX models with IHC data, 88% was observed. Of all the 180 PDX samples, 33 of the 43 PDX models (77%) have consistent predicted PAM50 molecular subtypes across different passages and lineages. Within the discordant samples, we observed cases such as a mixture of luminal B and Basal, which can be reasonably interpreted by AR positive signal from IHC. The discrepancy encourages further PDX subclassification from the Basal subtype. Conclusions: Using our high-throughput gene expression profiles from many patients and samples from patient derived models, we have demonstrated the feasibility of applying classic PAM50 classification algorithm, which was originally developed with microarray data, to be able to recognize the expression signals from our RNA-seq data. Overall, this study should set a primer for the identification of PDX-based subtypes, starting from breast cancer. Citation Format: Peter I. Wu, Lindsay Dutko, Shahanawaz Jiwani, Li Chen, Biswajit Das, Ting-Chia Chang, Yvonne A. Evrard, Chris A. Karlovich, Alyssa Chapman, Brandie Fullmer, Ashley Hayes, Ruth Thornton, Nikitha Nair, Kelly Benauer, Gloryvee Rivera, Thomas Forbes, John Carter, Suzanne Borgel, Tiffanie Miner, Chelsea McGlynn, Justine Mills, Shannon Uzelac, Tia Shearer, Lauren Hicks, Michelle Norris, Carley Border, Sergio Alcoser, Thomas Walsh, Michael Mullendore, Michelle Eugeni, Dianne Newton, Melinda G. Hollingshead, P. M. Williams, James H. Doroshow. Molecular subclassification of NCI PDMR breast cancer models using PAM50 gene expression signature [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2050." @default.
• W4362597265 created "2023-04-06" @default.
• W4362597265 creator A5006623171 @default.
• W4362597265 creator A5007381691 @default.
• W4362597265 creator A5011216065 @default.
• W4362597265 creator A5013918494 @default.
• W4362597265 creator A5014178153 @default.
• W4362597265 creator A5014611111 @default.
• W4362597265 creator A5016211896 @default.
• W4362597265 creator A5021237144 @default.
• W4362597265 creator A5022166540 @default.
• W4362597265 creator A5022514080 @default.
• W4362597265 creator A5026551932 @default.
• W4362597265 creator A5028990211 @default.
• W4362597265 creator A5037989560 @default.
• W4362597265 creator A5038405039 @default.
• W4362597265 creator A5039374231 @default.
• W4362597265 creator A5041200743 @default.
• W4362597265 creator A5043469721 @default.
• W4362597265 creator A5044153234 @default.
• W4362597265 creator A5048980029 @default.
• W4362597265 creator A5051332415 @default.
• W4362597265 creator A5053025161 @default.
• W4362597265 creator A5053345939 @default.
• W4362597265 creator A5054948261 @default.
• W4362597265 creator A5061830496 @default.
• W4362597265 creator A5062402200 @default.
• W4362597265 creator A5066106192 @default.
• W4362597265 creator A5072095812 @default.
• W4362597265 creator A5072749934 @default.
• W4362597265 creator A5074997319 @default.
• W4362597265 creator A5076688286 @default.
• W4362597265 creator A5080778766 @default.
• W4362597265 creator A5080843003 @default.
• W4362597265 creator A5082055457 @default.
• W4362597265 creator A5091723132 @default.
• W4362597265 date "2023-04-04" @default.
• W4362597265 modified "2023-09-27" @default.
• W4362597265 title "Abstract 2050: Molecular subclassification of NCI PDMR breast cancer models using PAM50 gene expression signature" @default.
• W4362597265 doi "https://doi.org/10.1158/1538-7445.am2023-2050" @default.
• W4362597265 hasPublicationYear "2023" @default.
• W4362597265 type Work @default.
• W4362597265 citedByCount "0" @default.
• W4362597265 crossrefType "journal-article" @default.
• W4362597265 hasAuthorship W4362597265A5006623171 @default.
• W4362597265 hasAuthorship W4362597265A5007381691 @default.
• W4362597265 hasAuthorship W4362597265A5011216065 @default.
• W4362597265 hasAuthorship W4362597265A5013918494 @default.
• W4362597265 hasAuthorship W4362597265A5014178153 @default.
• W4362597265 hasAuthorship W4362597265A5014611111 @default.
• W4362597265 hasAuthorship W4362597265A5016211896 @default.
• W4362597265 hasAuthorship W4362597265A5021237144 @default.
• W4362597265 hasAuthorship W4362597265A5022166540 @default.
• W4362597265 hasAuthorship W4362597265A5022514080 @default.
• W4362597265 hasAuthorship W4362597265A5026551932 @default.
• W4362597265 hasAuthorship W4362597265A5028990211 @default.
• W4362597265 hasAuthorship W4362597265A5037989560 @default.
• W4362597265 hasAuthorship W4362597265A5038405039 @default.
• W4362597265 hasAuthorship W4362597265A5039374231 @default.
• W4362597265 hasAuthorship W4362597265A5041200743 @default.
• W4362597265 hasAuthorship W4362597265A5043469721 @default.
• W4362597265 hasAuthorship W4362597265A5044153234 @default.
• W4362597265 hasAuthorship W4362597265A5048980029 @default.
• W4362597265 hasAuthorship W4362597265A5051332415 @default.
• W4362597265 hasAuthorship W4362597265A5053025161 @default.
• W4362597265 hasAuthorship W4362597265A5053345939 @default.
• W4362597265 hasAuthorship W4362597265A5054948261 @default.
• W4362597265 hasAuthorship W4362597265A5061830496 @default.
• W4362597265 hasAuthorship W4362597265A5062402200 @default.
• W4362597265 hasAuthorship W4362597265A5066106192 @default.
• W4362597265 hasAuthorship W4362597265A5072095812 @default.
• W4362597265 hasAuthorship W4362597265A5072749934 @default.
• W4362597265 hasAuthorship W4362597265A5074997319 @default.
• W4362597265 hasAuthorship W4362597265A5076688286 @default.
• W4362597265 hasAuthorship W4362597265A5080778766 @default.
• W4362597265 hasAuthorship W4362597265A5080843003 @default.
• W4362597265 hasAuthorship W4362597265A5082055457 @default.
• W4362597265 hasAuthorship W4362597265A5091723132 @default.
• W4362597265 hasConcept C121608353 @default.
• W4362597265 hasConcept C126322002 @default.
• W4362597265 hasConcept C143998085 @default.
• W4362597265 hasConcept C204232928 @default.
• W4362597265 hasConcept C502942594 @default.
• W4362597265 hasConcept C530470458 @default.
• W4362597265 hasConcept C60644358 @default.
• W4362597265 hasConcept C71924100 @default.
• W4362597265 hasConcept C86803240 @default.
• W4362597265 hasConceptScore W4362597265C121608353 @default.
• W4362597265 hasConceptScore W4362597265C126322002 @default.
• W4362597265 hasConceptScore W4362597265C143998085 @default.
• W4362597265 hasConceptScore W4362597265C204232928 @default.
• W4362597265 hasConceptScore W4362597265C502942594 @default.
• W4362597265 hasConceptScore W4362597265C530470458 @default.
• W4362597265 hasConceptScore W4362597265C60644358 @default.
• W4362597265 hasConceptScore W4362597265C71924100 @default.
• W4362597265 hasConceptScore W4362597265C86803240 @default.
• W4362597265 hasIssue "7_Supplement" @default.
• W4362597265 hasLocation W43625972651 @default.

• next